{"id":144386,"date":"2025-02-05T12:33:58","date_gmt":"2025-02-05T07:03:58","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=144386"},"modified":"2025-02-05T12:34:01","modified_gmt":"2025-02-05T07:04:01","slug":"pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/","title":{"rendered":"Pharma stock hits 20% upper circuit after reporting 458% QoQ increase in\u00a0 net profits\u00a0"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3764032333\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Microcap research-driven pharma stock is in focus as it hit&nbsp; 20% upper circuit after reporting its Q3 results with impressive growth in its net profits.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3944819878\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Share Price Movement<\/strong><\/h2><p>With a market capitalization of \u20b9469 Crore, the stock of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/VENUSREM\" target=\"_blank\" rel=\"noreferrer noopener\">Venus Remedies Limited<\/a><\/strong> opened at \u20b9329, up 12.38 % from yesterday&#8217;s closing price. After opening the stock quickly went up to hit 20% upper circuit at 351.30 Additionally, the 1 month&#8217;s return for the stock is 16 %, and the past year&#8217;s return is at -9 %.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Q3FY25 Results<\/strong><\/h2><p>The company reported a 23.31 % YoY increase in revenue from \u20b9143.42 Crore in Q3FY24 to \u20b9176.86 Crore in Q3FY25. On a QoQ basis, the company reported an increase of 5.32 % in revenue from \u20b9167.45 Crore in the previous quarter.<\/p><p>Their Net profit saw an increase of 186.12 % YoY from \u20b96.85 Crore to \u20b919.60 Crore for the same period. On a QoQ basis, the company reported an impressive increase of 458.40 % in revenue from \u20b93.51 Crore in the previous quarter.<\/p><div class=\"trade-content_5\" id=\"trade-2944992336\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Update from Company<\/strong><\/h2><p>The Board of the company has resolved to write off time-bared unsecured Foreign Currency Convertible (FCCB) liability of \u20b938.68 Crore including interest, which has remained unclaimed for over 10 years and is no longer legally enforceable under applicable laws.<\/p><p>The amount of FCCB liability of \u20b928.77 Crore has been transferred to the Capital Reserve, while the accrued interest of \u20b99.91 Crore being revenue in nature has been recognized as an exceptional item.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the Company<\/strong><\/h2><p>Venus Remedies Limited is an Indian pharmaceutical company specializing in critical care medicines, oncology, antibiotics, and pain management drugs. Established in 1989, the company has a presence in over 96 countries and is known for manufacturing advanced antimicrobial and cancer treatment solutions. With a strong focus on research and innovation, Venus Remedies develops cutting-edge therapies to combat antimicrobial resistance (AMR) and improve global healthcare.<\/p><blockquote class=\"wp-block-quote has-medium-font-size is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written By Abhishek Das<\/strong><\/p><\/blockquote><p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-2632153131\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Microcap research-driven pharma stock is in focus as it hit&nbsp; 20% upper circuit after reporting its Q3 results with impressive growth in its net profits. Share Price Movement With a market capitalization of \u20b9469 Crore, the stock of Venus Remedies Limited opened at \u20b9329, up 12.38 % from yesterday&#8217;s closing price. After opening the stock [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[8071,6616,26841,948,936,2597,19485,9806,26026,25201,26842,9805,9807],"class_list":["post-144386","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-20-upper-circuit-stock","tag-pharma-stock","tag-pharma-stock-hits-20-upper-circuit","tag-stock-market","tag-stock-market-news","tag-stocks-to-watch","tag-venus-remedies","tag-venus-remedies-latest-news","tag-venus-remedies-limited","tag-venus-remedies-news","tag-venus-remedies-resluts","tag-venus-remedies-share-price","tag-why-is-venus-remedies-going-up"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock hits 20% upper circuit after reporting 458% QoQ increase in\u00a0 net profits\u00a0 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Microcap research-driven pharma stock is in focus as it hit\u00a0 20% upper circuit after reporting its Q3 results with impressive growth in its net profits.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock hits 20% upper circuit after reporting 458% QoQ increase in\u00a0 net profits\u00a0\" \/>\n<meta property=\"og:description\" content=\"Microcap research-driven pharma stock is in focus as it hit\u00a0 20% upper circuit after reporting its Q3 results with impressive growth in its net profits.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-05T07:03:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-05T07:04:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/\",\"name\":\"Pharma stock hits 20% upper circuit after reporting 458% QoQ increase in\u00a0 net profits\u00a0 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2025-02-05T07:03:58+00:00\",\"dateModified\":\"2025-02-05T07:04:01+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Microcap research-driven pharma stock is in focus as it hit\u00a0 20% upper circuit after reporting its Q3 results with impressive growth in its net profits.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock hits 20% upper circuit after reporting 458% QoQ increase in\u00a0 net profits\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock hits 20% upper circuit after reporting 458% QoQ increase in\u00a0 net profits\u00a0 - Trade Brains Features","description":"Microcap research-driven pharma stock is in focus as it hit\u00a0 20% upper circuit after reporting its Q3 results with impressive growth in its net profits.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock hits 20% upper circuit after reporting 458% QoQ increase in\u00a0 net profits\u00a0","og_description":"Microcap research-driven pharma stock is in focus as it hit\u00a0 20% upper circuit after reporting its Q3 results with impressive growth in its net profits.","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2025-02-05T07:03:58+00:00","article_modified_time":"2025-02-05T07:04:01+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/","name":"Pharma stock hits 20% upper circuit after reporting 458% QoQ increase in\u00a0 net profits\u00a0 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2025-02-05T07:03:58+00:00","dateModified":"2025-02-05T07:04:01+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Microcap research-driven pharma stock is in focus as it hit\u00a0 20% upper circuit after reporting its Q3 results with impressive growth in its net profits.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-reporting-458-qoq-increase-in-net-profits\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock hits 20% upper circuit after reporting 458% QoQ increase in\u00a0 net profits\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=144386"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144386\/revisions"}],"predecessor-version":[{"id":144387,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144386\/revisions\/144387"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=144386"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=144386"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=144386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}